Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesThe cumulative burden of oral corticosteroid side effects and the economic implications of steroid use
Respiratory Medicine, 06/19/09
Manson SC et al. - A cumulative economic analysis of selected adverse events found the annual cost of treating these events in the UK to be at least £165 per patient taking OCS. The clinical and economic burden of OCS related adverse events highlights the need for OCS sparing therapies to be developed.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Oral Immunotherapy with inactivated NTHi reduces severity of acute exacerbations in severe COPD
Chest, 12/16/09
Use of oseltamivir in children
Canadian Family Physician, 12/16/09
Measuring exacerbations in obstructive lung disease
Pharmacoepidemiology and Drug Safety, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor